The overall goal of this proposal is to support my lifetime career commitment to understanding the molecular mechanism of opioid actions and, more specifically, to search for the molecular basis of opioid tolerance. The current proposal aims to study the molecular details in tissue- (or cell-) specific regulation of opioid gene expression and to test the hypothesis that the alteration of mu-opioid receptor synthesis and regulation is related to the mechanism of morphine action and tolerance. To achieve this goal, we plan to carry out two independent but related studies: 1) to determine the regulation of mu-opioid receptor gene expression which controls the synthesis of receptors in specific cells. We hypothesize that the differences in spatial and temporal expression of mu-opioid receptor gene are caused by (or resultant of) characteristic interactions between cis- and trans-regulatory elements using in vitro and in vivo models, 2) to determine the molecular mechanism of mu-opioid receptor regulation by a chemical modification (i.e., phosphorylation) and determine its possible relationship to morphine tolerance. In these studies, we aim to elucidate the exact role of receptor phosphorylation/dephosphorylation on cellular adaptation of chronic opioid treatment (i.e., tolerance). We also plan to pinpoint the exact phosphorylation sites of cloned opioid receptors that are involved in receptor desensitization, as well as to determine the protein kinases (or other protein factors) that are involved in this process. Finally, we plan to test the in vivo significance of this receptor modification in tolerance through a gene targeting approach.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Scientist Award (K05)
Project #
2K05DA070554-32
Application #
6780141
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Koustova, Elena
Project Start
1989-08-01
Project End
2009-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
32
Fiscal Year
2004
Total Cost
$127,818
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Pharmacology
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Wagley, Yadav; Hwang, Cheol Kyu; Lin, Hong-Yiou et al. (2013) Inhibition of c-Jun NH2-terminal kinase stimulates mu opioid receptor expression via p38 MAPK-mediated nuclear NF-?B activation in neuronal and non-neuronal cells. Biochim Biophys Acta 1833:1476-88
Song, Kyu Young; Choi, Hack Sun; Law, Ping-Yee et al. (2012) Post-transcriptional regulation of mu-opioid receptor: role of the RNA-binding proteins heterogeneous nuclear ribonucleoprotein H1 and F. Cell Mol Life Sci 69:599-610
Hwang, Cheol Kyu; Wagley, Yadav; Law, Ping-Yee et al. (2012) MicroRNAs in opioid pharmacology. J Neuroimmune Pharmacol 7:808-19
Zheng, Hui; Chu, Ji; Zhang, Yuhan et al. (2011) Modulating micro-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKCepsilon activation and dendritic spine stability. J Biol Chem 286:12724-33
Kim, Do Kyung; Hwang, Cheol Kyu; Wagley, Yadav et al. (2011) p38 mitogen-activated protein kinase and PI3-kinase are involved in up-regulation of mu opioid receptor transcription induced by cycloheximide. J Neurochem 116:1077-87
Wei, Li-Na; Loh, Horace H (2011) Transcriptional and epigenetic regulation of opioid receptor genes: present and future. Annu Rev Pharmacol Toxicol 51:75-97
Zheng, Hui; Zeng, Yan; Chu, Ji et al. (2010) Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability. J Neurosci 30:8102-10
Zheng, Hui; Loh, Horace H; Law, Ping-Yee (2010) Agonist-selective signaling of G protein-coupled receptor: mechanisms and implications. IUBMB Life 62:112-9
Zheng, Hui; Chu, Ji; Zeng, Yan et al. (2010) Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression. J Biol Chem 285:21994-2002
Zheng, Hui; Zeng, Yan; Zhang, Xiaoxiao et al. (2010) mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD. Mol Pharmacol 77:102-9

Showing the most recent 10 out of 70 publications